Huibo Wang

479 total citations
13 papers, 321 citations indexed

About

Huibo Wang is a scholar working on Oncology, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Huibo Wang has authored 13 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Molecular Biology and 3 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Huibo Wang's work include Cancer Immunotherapy and Biomarkers (2 papers), Autophagy in Disease and Therapy (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Huibo Wang is often cited by papers focused on Cancer Immunotherapy and Biomarkers (2 papers), Autophagy in Disease and Therapy (2 papers) and Cardiac Fibrosis and Remodeling (2 papers). Huibo Wang collaborates with scholars based in China and United States. Huibo Wang's co-authors include Wei Li, Yanhong Tang, Mingxin Liu, Lin Yin, Qizhu Tang, Sihui Huang, Chun‐Xia Wan, Wei Deng, Congxin Huang and Man Xu and has published in prestigious journals such as The FASEB Journal, Biochemical and Biophysical Research Communications and Journal of Cellular Physiology.

In The Last Decade

Huibo Wang

13 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Huibo Wang China 8 163 80 76 57 47 13 321
Daniela Haase Germany 12 172 1.1× 79 1.0× 61 0.8× 54 0.9× 59 1.3× 19 367
Zhi‐Ren Zhang China 11 181 1.1× 135 1.7× 46 0.6× 60 1.1× 26 0.6× 25 381
Pang‐Bo Li China 12 197 1.2× 104 1.3× 48 0.6× 36 0.6× 46 1.0× 16 332
Manhua Chen China 11 209 1.3× 52 0.7× 99 1.3× 59 1.0× 19 0.4× 15 341
Jingtian Peng China 11 165 1.0× 150 1.9× 41 0.5× 44 0.8× 34 0.7× 13 351
Feifeng Ren China 11 130 0.8× 46 0.6× 109 1.4× 35 0.6× 42 0.9× 24 363
Qiuting Feng China 12 286 1.8× 94 1.2× 42 0.6× 88 1.5× 31 0.7× 18 385
Saien Lu China 11 273 1.7× 58 0.7× 65 0.9× 83 1.5× 68 1.4× 20 426
Yuanming Zou China 8 227 1.4× 61 0.8× 36 0.5× 89 1.6× 32 0.7× 14 363
Soo Hyuk Kim South Korea 11 171 1.0× 84 1.1× 41 0.5× 92 1.6× 46 1.0× 14 388

Countries citing papers authored by Huibo Wang

Since Specialization
Citations

This map shows the geographic impact of Huibo Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibo Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibo Wang more than expected).

Fields of papers citing papers by Huibo Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huibo Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibo Wang. The network helps show where Huibo Wang may publish in the future.

Co-authorship network of co-authors of Huibo Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Huibo Wang. A scholar is included among the top collaborators of Huibo Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huibo Wang. Huibo Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
2.
Wang, Huibo, Qi Sun, Hui Pang, et al.. (2024). Comparison of the efficacy of taxanes with carboplatin and anthracyclines with taxanes in neoadjuvant chemotherapy for stage II–III triple negative breast cancer: a retrospective analysis. Journal of Cancer Research and Clinical Oncology. 150(6). 291–291. 4 indexed citations
3.
4.
5.
Huang, Sihui, Man Xu, Libo Liu, et al.. (2020). Autophagy is involved in the protective effect of p21 on LPS-induced cardiac dysfunction. Cell Death and Disease. 11(7). 554–554. 35 indexed citations
6.
Yang, Kang, Huibo Wang, Yusha Xiao, et al.. (2020). MFAP4 deficiency alleviates renal fibrosis through inhibition of NF‐κB and TGF‐β/Smad signaling pathways. The FASEB Journal. 34(11). 14250–14263. 39 indexed citations
7.
Xu, Man, Chun‐Xia Wan, Sihui Huang, et al.. (2019). Oridonin protects against cardiac hypertrophy by promoting P21-related autophagy. Cell Death and Disease. 10(6). 403–403. 67 indexed citations
8.
Liu, Mingxin, Lin Yin, Wei Li, et al.. (2019). C1q/TNF‐related protein‐9 promotes macrophage polarization and improves cardiac dysfunction after myocardial infarction. Journal of Cellular Physiology. 234(10). 18731–18747. 49 indexed citations
9.
Liu, Mingxin, Wei Li, Huibo Wang, et al.. (2019). CTRP9 Ameliorates Atrial Inflammation, Fibrosis, and Vulnerability to Atrial Fibrillation in Post‐Myocardial Infarction Rats. Journal of the American Heart Association. 8(21). e013133–e013133. 58 indexed citations
10.
Yang, Jun, Xiaowen Liu, Jiawang Ding, et al.. (2018). Down-Regulation of miR-327 Alleviates Ischemia/Reperfusion-Induced Myocardial Damage by Targeting RP105. Cellular Physiology and Biochemistry. 49(3). 1090–1104. 36 indexed citations
11.
Yang, Jian, Zhixing Fan, Chaojun Yang, & Huibo Wang. (2015). A Meta-Analysis of Randomized Clinical Trials Comparing Shorter (Less or Equal Than 6 Months) and Longer (More or Equal Than 12 Months) Dual Anti-Platelet Therapy Following Drug-Eluting Coronary Stents. Iranian Red Crescent Medical Journal. 17(7). e26904–e26904. 1 indexed citations
12.
Wang, Huibo, et al.. (2013). Epidemiological Data Analysis in TerraFly Geo-spatial Cloud. 171. 485–490. 1 indexed citations
13.
Wang, Shuai, Huibo Wang, Jiyong Liang, et al.. (2011). PARP1 inhibitors attenuate AKT phosphorylation via the upregulation of PHLPP1. Biochemical and Biophysical Research Communications. 412(2). 379–384. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniela Haase Breakdown of academic impact, for papers by Zhi‐Ren Zhang Breakdown of academic impact, for papers by Pang‐Bo Li Breakdown of academic impact, for papers by Manhua Chen Breakdown of academic impact, for papers by Jingtian Peng Breakdown of academic impact, for papers by Feifeng Ren Breakdown of academic impact, for papers by Qiuting Feng Breakdown of academic impact, for papers by Saien Lu Breakdown of academic impact, for papers by Yuanming Zou Breakdown of academic impact, for papers by Soo Hyuk Kim
Rankless by CCL
2026